While all states and D.C. have adopted at least one policy related to treatment access for patients suffering from opioid addiction, no state adopted all the policies analyzed, leaving potential barriers in place.
Other featured articles
Top Schaeffer Studies of 2021
Over the past year, Schaeffer Center experts authored over 130 journal articles and 14 white papers. They were also in the media about 5,500 times, including authoring over 40 op-eds and blog posts. Below is a look back at a few of the most impactful studies from 2021.
Who Are the Winners in the No Surprises Act?
With the No Surprises Act set to take effect January 1, HHS is resisting a push from some doctor groups to weaken implementation rules of the legislation, and that’s a good thing. The law is a big win for patients, employers, and consumers.
More than Half of Insulin Expenditures Going to Middlemen, New USC Schaeffer Study Finds
Schaeffer research offers one of the most comprehensive looks at the insulin distribution chain and shows which players are profiting, and by how much, from selling insulin.
Hesitancy Plays Increasing Role in Vaccine Coverage Disparities Despite Wide Availability
Social vulnerability was also independently associated with widening disparities in county-level coverage, signaling the need for unique, targeted interventions.
Schaeffer Insightsmore data
The Leonard D. Schaeffer Center for Health Policy & Economics, one of the nation’s premier policy centers, measurably improves value in health through evidence-based policy solutions, research excellence, and private- and public-sector engagement.about
More from Schaeffer
Our Policy Areas
From aging to drug pricing to health disparities, Schaeffer Center experts are advancing research to inform policy. Learn about the areas we work in.Learn More
Work & Study at USC
The Schaeffer Center develops innovators for positions in higher education, research, government and healthcare through degree programs and postgraduate opportunities.Learn More